{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:13:22Z","timestamp":1778699602472,"version":"3.51.4"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0118610","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T18:50:39Z","timestamp":1425408639000},"page":"e0118610","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity"],"prefix":"10.1371","volume":"10","author":[{"given":"Mar\u00eda","family":"Pedraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"Mart\u00edn-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Garc\u00eda-Marchena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Araos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Romero-Sanchiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Castilla-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Campos-Cloute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jes\u00fas","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Torrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Ann","family":"Chowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Javier","family":"Sant\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Villan\u00faa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rodr\u00edguez de Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjp.2008.77","article-title":"Neuroplasticity in the mesolimbic dopamine system and cocaine addiction","volume":"154","author":"MJ Thomas","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pharmthera.2012.01.010","article-title":"2nd. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate","volume":"134","author":"CN Haile","year":"2012","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuropharm.2004.06.025","article-title":"Structural plasticity associated with exposure to drugs of abuse","volume":"47","author":"TE Robinson","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1360-0443.2007.02076.x","article-title":"Psychiatric comorbidity in young cocaine users: induced versus independent disorders","volume":"103","author":"MJ Herrero","year":"2008","journal-title":"Addiction"},{"key":"ref5","first-page":"18","article-title":"Elevated IGF1 in clinical opiate dependence","volume":"34","author":"AS Reece","year":"2013","journal-title":"Neuro Endocrinol Lett"},{"key":"ref6","first-page":"15","article-title":"Psychopathological comorbidity in cocaine users in outpatient treatment","volume":"26","author":"P Araos","year":"2014","journal-title":"Adicciones"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1176\/appi.ajp.161.7.1231","article-title":"Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV","volume":"161","author":"M Torrens","year":"2004","journal-title":"Am J Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF03033361","article-title":"Importance of clinical diagnoses for comorbidity studies in substance use disorders","volume":"10","author":"M Torrens","year":"2006","journal-title":"Neurotox Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","article-title":"Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections","volume":"5","author":"E Domenici","year":"2010","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11920-011-0224-0","article-title":"New findings on biological factors predicting addiction relapse vulnerability","volume":"13","author":"R Sinha","year":"2011","journal-title":"Curr Psychiatry Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17530059.1.2.235","article-title":"The search for peripheral disease markers in psychiatry by genomic and proteomic approaches","volume":"1","author":"E Domenici","year":"2007","journal-title":"Expert Opin Med Diagn"},{"key":"ref12","article-title":"Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity","author":"P Araos","year":"2014","journal-title":"Addict Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/adb.12107","article-title":"Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity","volume":"18","author":"FJ Pavon","year":"2013","journal-title":"Addict Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/MN:29:3:289","article-title":"Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection","volume":"29","author":"E Castren","year":"2004","journal-title":"Mol Neurobiol"},{"key":"ref15","first-page":"1","article-title":"Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder","author":"M Corominas-Roso","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2011.05.013","article-title":"Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study","volume":"70","author":"C D\u2019Sa","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.euroneuro.2012.08.016","article-title":"Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence","volume":"23","author":"M Corominas-Roso","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000353259","article-title":"Serum brain-derived neurotrophic factor levels and cocaine-induced transient psychotic symptoms","volume":"68","author":"M Corominas-Roso","year":"2013","journal-title":"Neuropsychobiology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yfrne.2012.06.002","article-title":"Neurodevelopmental effects of insulin-like growth factor signaling","volume":"33","author":"J O\u2019Kusky","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dneu.20778","article-title":"Toward a comprehensive neurobiology of IGF-I","volume":"70","author":"I Torres-Aleman","year":"2010","journal-title":"Dev Neurobiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/sj.npp.1301358","article-title":"Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects","volume":"32","author":"JE Malberg","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1038\/tp.2013.102","article-title":"Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice","volume":"3","author":"A Trueba-Saiz","year":"2013","journal-title":"Transl Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psyneuen.2014.01.006","article-title":"Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults","volume":"42","author":"F Lin","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0306-4530(02)00045-8","article-title":"Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy","volume":"28","author":"PJ Stouthart","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1530-0277.2007.00589.x","article-title":"Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients","volume":"32","author":"L Leggio","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/ajp.153.9.1195","article-title":"Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers","volume":"153","author":"DS Hasin","year":"1996","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","article-title":"The Composite International Diagnostic Interview\u2014an Epidemiologic Instrument Suitable for Use in Conjunction with Different Diagnostic Systems and in Different Cultures","volume":"45","author":"LN Robins","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/ajp.2006.163.4.689","article-title":"Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV","volume":"163","author":"D Hasin","year":"2006","journal-title":"Am J Psychiatry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mpr.189","article-title":"Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium","volume":"15","author":"S Morgello","year":"2006","journal-title":"Int J Methods Psychiatr Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2011.09.005","article-title":"Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients","volume":"122","author":"DS Hasin","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"DS Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ejn.12012","article-title":"Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats","volume":"37","author":"P Rivera","year":"2013","journal-title":"Eur J Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"70ra13","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"J Guevara-Aguirre","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1474-9726.2009.00493.x","article-title":"Association of common genetic variation in the insulin\/IGF1 signaling pathway with human longevity","volume":"8","author":"L Pawlikowska","year":"2009","journal-title":"Aging Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1474-9728.2005.00148.x","article-title":"Reduced insulin\/IGF-1 signalling and human longevity","volume":"4","author":"D van Heemst","year":"2005","journal-title":"Aging Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1503\/jpn.130027","article-title":"Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress","volume":"39","author":"TW Viola","year":"2014","journal-title":"J Psychiatry Neurosci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1007\/s00213-014-3542-1","article-title":"Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal","volume":"231","author":"AO Sordi","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S146114571300103X","article-title":"Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal","volume":"17","author":"L von Diemen","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2014.07.005","article-title":"Aging and age-related diseases\u2014From endocrine therapy to target therapy","volume":"394","author":"Q Bao","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nrendo.2013.67","article-title":"The GH\/IGF-1 axis in ageing and longevity","volume":"9","author":"RK Junnila","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mcn.2011.07.008","article-title":"Reduced brain insulin-like growth factor I function during aging","volume":"49","author":"AP Muller","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pneurobio.2009.07.008","article-title":"Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan","volume":"89","author":"A Aleman","year":"2009","journal-title":"Prog Neurobiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0361-9230(96)00045-7","article-title":"Central opiate modulation of growth hormone and insulin-like growth factor-I","volume":"40","author":"Y Hashiguchi","year":"1996","journal-title":"Brain Res Bull"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1749-6632.1993.tb26223.x","article-title":"Chronic morphine decreases insulin-like growth factor-I levels in the ventral tegmental area of the rat brain","volume":"692","author":"D Beitner-Johnson","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/alcalc\/agm065","article-title":"Brain atrophy in alcoholics: relationship with alcohol intake; liver disease; nutritional status, and inflammation","volume":"42","author":"E Garcia-Valdecasas-Campelo","year":"2007","journal-title":"Alcohol Alcohol"},{"issue":"Suppl 1","key":"ref46","doi-asserted-by":"crossref","first-page":"i49","DOI":"10.1093\/alcalc\/agu053.56","article-title":"Or12\u20132the relationship between insulin-like growth factor-1 and cognitive function in alcohol-dependent patient","volume":"49","author":"C Han","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"ref47","first-page":"48","article-title":"Determinants of circulating insulin-like growth factor-I","volume":"22","author":"K Hall","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"AR Brunoni","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/15622971003611319","article-title":"Serum and plasma BDNF levels in major depression: a replication study and meta-analyses","volume":"11","author":"L Bocchio-Chiavetto","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2007.05.005","article-title":"Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments","volume":"105","author":"A Piccinni","year":"2008","journal-title":"J Affect Disord"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2006.06.024","article-title":"Low plasma BDNF is associated with suicidal behavior in major depression","volume":"31","author":"YK Kim","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref52","first-page":"1","article-title":"Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels","author":"AR Rosa","year":"2014","journal-title":"Psychol Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2013.01.054","article-title":"Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women","volume":"156","author":"HA Kenna","year":"2014","journal-title":"J Affect Disord"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"K Martinowich","year":"2007","journal-title":"Nat Neurosci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1038\/tp.2012.126","article-title":"Associations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels","volume":"2","author":"R Dalle Molle","year":"2012","journal-title":"Transl Psychiatry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnint.2013.00055","article-title":"Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis","volume":"7","author":"S Suliman","year":"2013","journal-title":"Front Integr Neurosci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0306-4530(97)00046-2","article-title":"Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients","volume":"22","author":"M Deuschle","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psychres.2014.03.042","article-title":"Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder","volume":"218","author":"X Liu","year":"2014","journal-title":"Psychiatry Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0118610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T15:54:51Z","timestamp":1717775691000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0118610"}},"subtitle":[],"editor":[{"given":"Robert N.","family":"Pechnick","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,3]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0118610","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,3]]}}}